Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

2.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

3.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

4.

New analysis helps discern benign from malignant thyroid growths

5.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot